Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0635-2020

Drug recall · January 8, 2020

Bimatoprost Ophthalmic Solution recall

Why: Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.

Lots / codes

Lot# H801686, Exp. 12/31/2019.

Quantity
2,130 bottles
Company
Lupin Pharmaceuticals Inc., Baltimore, MD
Distribution
Nationwide in the U.S.
Initiated
December 13, 2019 · Voluntary: Firm initiated
Classified
January 2, 2020
Reported
January 8, 2020
Ended
October 19, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Bimatoprost

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.